NEPHRO CARE INDIA LIMITED Financial Ratios
NEPHROCARE · Healthcare Services · Current price ₹65.45
P/E ratio
29.6x
P/B ratio
2.0x
ROE
6.1%
ROCE
11.3%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 29.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 6.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 11.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with NEPHRO CARE INDIA LIMITED's latest numbers.
NEPHRO CARE INDIA LIMITED profitability
NEPHRO CARE INDIA LIMITED generates a return on equity of 6.1% and a return on capital employed of 11.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 29.6x, NEPHRO CARE INDIA LIMITED is conservatively financed. Our overall business-quality score for the company is 4.3 / 10.
Understand the ratios
More on NEPHRO CARE INDIA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.